Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001949693-26-000002
Filing Date
2026-03-18
Accepted
2026-03-18 16:06:33
Documents
2
Period of Report
2026-03-16

Document Format Files

Seq Description Document Type Size
1 form4-03182026_080328.html 4  
1 form4-03182026_080328.xml 4 4108
2 ex24-03182026_080328.htm EX-24 6441
  Complete submission text file 0001949693-26-000002.txt   12064
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Issuer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O PASSAGE BIO, INC. 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address
Chou William (Reporting) CIK: 0001949693 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39231 | Film No.: 26768933